Clinical case of COVID-19 in an HIV-infected teenager

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The problem of non-smooth course of COVID-19 in people with severe comorbidities is topical. The greatest number of deaths from a new coronavirus infection was noted in the presence of such diseases as: obesity, chronic bronchopulmonary, cardiovascular diseases, HIV infection, diabetes mellitus, oncohematology, etc. Due to the focus of the healthcare system on the COVID-19 pandemic, less attention is paid to the fight against the immunodeficiency virus, despite the fact that the epidemiological situation with HIV infection in the Russian Federation continues to be tense. Individuals with HIV infection may be at increased risk of complications and death associated with COVID-19. The stage of HIV infection, indicators of the immune status, viremia, and taking antiretroviral therapy correlate with the severity of the course of COVID-19/HIV and have prognostic value. A clinical observation of the course of a new coronavirus infection in a 15-year-old teenager born to an HIV infected mother (who hid her HIV status at the time of hospitalization of a child) who was not at a dispensary observation at the AIDS Center was presented. The child was hospitalized with a new coronavirus infection (COVID-19), complicated: acute community-acquired (interstitial) bilateral pneumonia. The low index body mass of the child, the presence of concomitant pathology, the non-smooth course of the disease made it possible to suspect the patient of an immunodeficiency condition and identify concomitant HIV infection in the secondary disease stage (4B), the progression phase with the absence of antiretroviral therapy. Conclusion: the non-smooth course and severity of the disease were mainly due to secondary infections pathology. Severe immunosuppression detected in a child due to HIV infection contributed to the long-term persistence of the SARS-CoV-2 virus. In this case, it was not established that HIV infection in the patient was a factor predisposing to the severe course of COVID-19 and contributing to a prognostically unfavorable outcome. Complex therapy including antiretroviral therapy prevented further progression of immunosuppression and led to recovery from new coronavirus infection and management of comorbidity. The increase in the number of HIV-infected persons in the late stages of infection, often detected by chance, only during hospitalization, presents difficulties for therapy due to late diagnosis, the presence of a combined secondary pathology and the severity of its course against the background of low immune status parameters.

Full Text

Restricted Access

About the authors

Tatyana A. Kaplina

Saint Petersburg State Pediatric Medical University

Author for correspondence.
Email: k.kta@yandex.ru
ORCID iD: 0000-0003-1659-2058
SPIN-code: 1381-9580

MD, PhD, Associate Professor, Professor M.G. Danilevich Department of Infectious Diseases in Children

Russian Federation, Saint Petersburg

Dmitry O. Ivanov

Saint Petersburg State Pediatric Medical University

Email: doivanov@yandex.ru
ORCID iD: 0000-0002-0060-4168
SPIN-code: 4437-9626

MD, PhD, Dr. Sci. (Medicine), Professor, Chief Freelance Neonatologist of the Ministry of Health of Russia, Rector, Head of the Department of Neonatology with courses of Neurology and Obstetrics and Gynecology

Russian Federation, Saint Petersburg

Vladimir N. Timchenko

Saint Petersburg State Pediatric Medical University

Email: timchenko220853@yandex.ru
ORCID iD: 0000-0002-4068-1731
SPIN-code: 8594-0751

MD, PhD, Dr. Sci. (Medicine), Professor, Head, Professor M.G. Danilevich Department of Infectious Diseases in Children

Russian Federation, Saint Petersburg

Svetlana L. Bannova

Saint Petersburg State Pediatric Medical University

Email: deva0509@mail.ru
ORCID iD: 0000-0003-1351-1910
SPIN-code: 9654-9386

MD, PhD, Associate Professor, Professor M.G. Danilevich Department of Infectious Diseases in Children

Russian Federation, Saint Petersburg

Gleb V. Kondratyev

Saint Petersburg State Pediatric Medical University

Email: spbgvk@mail.ru
ORCID iD: 0000-0002-1462-6907
SPIN-code: 9092-3185

Assistant, Department of oncology, pediatric oncology and radiation therapy

Russian Federation, Saint Petersburg

Vera F. Sukhovetskaya

Saint Petersburg State Pediatric Medical University

Email: verafedotovna@mail.ru
ORCID iD: 0000-0002-1566-7137
SPIN-code: 3633-2952

MD, PhD, Associate Professor, Professor M.G. Danilevich Department of Infectious Diseases in Children

Russian Federation, Saint Petersburg

Maria D. Subbotina

Saint Petersburg State Pediatric Medical University

Email: m.03@bk.ru
ORCID iD: 0000-0001-8748-7146
SPIN-code: 1458-6062

MD, PhD, Associate Professor, Professor M.G. Danilevich Department of Infectious Diseases in Children

Russian Federation, Saint Petersburg

Elena B. Pavlova

Saint Petersburg State Pediatric Medical University

Email: infarm@bk.ru
ORCID iD: 0000-0002-7596-1004
SPIN-code: 8900-3143

Associate Professor, Department of Pharmacology with a course of clinical pharmacology, pharmacoeconomics

Russian Federation, Saint Petersburg

Anna N. Nazarova

Saint Petersburg State Pediatric Medical University

Email: anyta19@bk.ru
ORCID iD: 0000-0002-4678-4328
SPIN-code: 3375-2127

Assistant, Professor M.G. Danilevich Department of Infectious Diseases in Children

Russian Federation, Saint Petersburg

Anna V. Fedorova

Saint Petersburg State Pediatric Medical University

Email: aanna.fedorova@gmail.com
ORCID iD: 0000-0003-2870-4344

Assistant, Professor M.G. Danilevich Department of Infectious Diseases in Children

Russian Federation, Saint Petersburg

Oksana V. Bulina

Saint Petersburg State Pediatric Medical University

Email: oksanabulina@yandex.ru
ORCID iD: 0000-0002-2997-7777
SPIN-code: 7960-2040

Cand. Sci. (Medicine), Associate Professor, Department of Rehabilitology Faculty of Retraining and Additional Professional Education

Russian Federation, Saint Petersburg

References

  1. www.consultant.ru [Internet]. Temporary methodological recommendations «Prevention, diagnosis and treatment of a new coronavirus infection (COVID-19). Version 17 (14.12.2022). Available at: https://www.consultant.ru/document/cons_doc_LAW_347896/ (In Russ.)
  2. Ivanov DO, Petrenko YuV, Nasyrov RA, et al. Clinical case of COVID-19 course in a child with aplastic anemia. Journal Infectology. 2022;14(1):145–151. doi: 10.22625/2072-6732-2022-14-1-145-151
  3. Ivanov DO, Petrenko YuV, Reznik VA, et al. Characteristics of new coronavirus infection in patients with acute myeloid leukemia. Clinical Practice in Pediatrics. 2021;16(3):121–129. doi: 10.20953/1817-7646-2021-3-121-129
  4. Mazus AI, Nagibina MV, Bessarab TP, et al. COVID-19/HIV co-infection: characteristics of patients in the Moscow megalopolis. Therapy. 2021;(4):18–24. doi: 10.18565/therapy.2021.4.18-24
  5. Nesterenko ZV, Prokopyeva NE, Matalygina OA, et al. Community-acquired pneumonia in children during the coronavirus pandemic. Medicine: theory and practice. 2021;6(4):12–20.
  6. Federal Service for Supervision of Consumer Rights Protection and Human Welfare. On the state of sanitary-epidemiologic well-being of the population in the Russian Federation in 2021: State report. Moscow: Federal Service for Supervision of Consumer Rights Protection and Human Welfare, 2022. 340 p. (In Russ.)
  7. Reeva SV, Belousova TI, Parfenova NN, et al. Clinical case of systemic lupus erythematosus debut after an infection COVID-19. University therapeutic journal. 2022;4(S):30–31.
  8. Stepanova EV, Leonova ON, Shelomov AS, Vinogradova TN. Coronavirus infection in patients with HIV infection, features of the course. Journal Infectology. 2021;13(2):61–69. doi: 10.22625/2072-6732-2021-13-2-61-69
  9. Hakizimana J, Ivanov DO, Yastrebova EB, et al. Contemporary diagnosis of HIV infection in pediatrician’s practice. Pediatrician (St. Petersburg). 2020;11(3):73–80. doi: 10.17816/PED11373-80
  10. Zinserling VA, Vashukova MA, Vasilyeva MV, et al. Issues of pathology of a new coronavirus infection CoVID-19. Journal Infectology. 2020;12(2):5–11. doi: 10.22625/2072-6732-2020-12-2-5-11
  11. Shakmaeva MA, Chernova TM, Timchenko VN, et al. Features of a new Coronavirus infection in children of different ages. Children infections. 2021;20(2):5–9. doi: 10.22627/2072-8107-2021-20-2-5-9
  12. eacsociety.org [Internet]. BHIVA, DAIG, EACS, GESIDA and Polish Scientific AIDS Society Statement on risk of COVID-19 for people living with HIV (PLWH) [cited 2023 Jun 23]. Available at: https://www.eacsociety.org/home/bhiva-daig-eacs-gesida-polish-scientific-aids-society-statement-on-risk-of-covid-19-for-people-living-with-hiv-plwh/
  13. Blanco JL, Ambrosioni J, Garcia F, et al. COVID-19 in HIV Investigators. COVID-19 in patients with HIV: clinical case series. Lancet HIV. 2020;7(5):e314–e316. DOI: S2352-3018(20)30111-9
  14. Cao B, Wang Y, Wen D, et al. A trial of lopinavir-ritonavir in adults hospitalized with severe COVID-19. N Engl J Med. 2020;382: 1787–1799. doi: 10.1056/NEJMoa2001282
  15. www.cdc.gov [Internet]. CDC. 2019 novel coronavirus. Available at: https://www.cdc.gov/coronavirus/2019-ncov/index.html7
  16. Docherty AB, Harrison EM, Green CA, et al. Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO clinical characterization protocol. medRxiv. 2020;20076042. doi: 10.1101/2020.04.23.20076042
  17. Guo W, Ming F, Dong Y, et al. A Survey for COVID-19 among HIV/AIDS patients in two districts of Wuhan, China. Preprint with the Lancet. doi: 10.2139/ssrn.3550029
  18. Xu Z, Zhang C, Wang F-S. COVID-19 in people with HIV. Lancet HIV. 2020;7(8):e524–e526. doi: 10.1016/S2352-3018(20)30163-6
  19. Härter G, Spinner CD, Roider J, et al. COVID-19 in people living with human immunodeficiency virus: a case series of 33 patients. Infection. 2020;48(5):681–686. doi: 10.1007/s15010-020-01438-z
  20. Karmen-Tuohy S, Carlucci PM, Zacharioudakis IM, et al. Outcomes among HIV-positive patients hospitalized with COVID-19. medRxiv. 2020;20094797. doi: 10.1101/2020.05.07.20094797
  21. Kowalska JD, Skrzat-Klapaczyńska A, Bursa D, et al. HIV care in times of the COVID-19 crisis — where are we now in Central and Eastern Europe? Int J Infect Dis. 2020;96:311–314. doi: 10.1016/j.ijid.2020.05.013
  22. Heidary M, Asadi A, Noorbakhsh N, et al. COVID-19 in HIV-positive patients: A systematic review of case reports and case series. J Clin Lab Anal. 2022;36(4):e24308. doi: 10.1002/jcla.24308
  23. who.int [Internet]. World Health Organization. Infection prevention and control guidance for long-term care facilities in the context of COVID-19: interim guidance, 21 March 2020. Available at: https://apps.who.int/iris/handle/10665/331508
  24. Wu Q, Chen T, Zhang H. Recovery from COVID-19 in two patients with coexisted HIV infection. J Med Virol. 2020;92(11):2325–2327. doi: 10.1002/jmv.26006

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2023 Eco-Vector



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 69634 от 15.03.2021 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies